Association Between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell Carcinoma.
about
Current clinical immunotherapeutic approaches for head and neck cancerEvaluation of PD-L1 Expression in Tumor Tissue of Patients with Lung Carcinoma and Correlation with Clinical and Demographic Data.Prognostic value of programmed cell death ligand 1 expression in patients with head and neck cancer: A systematic review and meta-analysis.Association between PD-L1 and HPV status and the prognostic value for HPV treatment in premalignant cervical lesion patients.Epithelium Expressing the E7 Oncoprotein of HPV16 Attracts Immune-Modulatory Dendritic Cells to the Skin and Suppresses Their Antigen-Processing CapacityPD-L1 expression in tonsillar cancer is associated with human papillomavirus positivity and improved survival: implications for anti-PD1 clinical trials.The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.Systemic Treatment in HPV-Induced Recurrent or Metastatic HNSCC.Expressions of programmed death (PD)-1 and PD-1 ligand (PD-L1) in cervical intraepithelial neoplasia and cervical squamous cell carcinomas are of prognostic value and associated with human papillomavirus status.Human papillomavirus related oropharyngeal cancer.Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.Tumor PD-L1 status and CD8+ tumor-infiltrating T cells: markers of improved prognosis in oropharyngeal cancer.Programmed death-ligand 1 expression correlates with diminished CD8+ T cell infiltration and predicts poor prognosis in anal squamous cell carcinoma patients.Programmed cell death ligand 1 as a biomarker in head and neck cancer.Tumoral PD-L1 expression defines a subgroup of poor-prognosis vulvar carcinomas with non-viral etiology.Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years.Implications of the tumor immune microenvironment for staging and therapeutics.Beyond the Percentages of PD-L1-Positive Tumor Cells: Induced Versus Constitutive PD-L1 Expression in Primary and Metastatic Head and Neck Squamous Cell Carcinoma.Prognostic value of PD -L1 expression in patients with primary solid tumors.Genomic Landscapes of EBV-Associated Nasopharyngeal Carcinoma vs. HPV-Associated Head and Neck CancerActivation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide
P2860
Q26745411-7A089FB7-FD1F-494A-A1A4-8EF0177DA684Q31137039-95A55409-ECBC-45FA-9430-71C628468003Q33788235-A4AEDC78-A06F-4418-8784-264F444C46BEQ33833832-77EF5F76-5A57-4901-BE10-D1786EB1B34AQ35974911-6810D296-0EAF-42A5-946C-CFB4525E66B6Q37718331-23A83527-779A-461E-A7AC-95FCAF5EFE15Q38686682-07A59791-3714-4E2B-99C0-1FC766925078Q38742013-D026E543-8A19-46CF-8821-EB742390C728Q38971558-46E3EA32-35F5-4B99-B1C8-55C62FBFAA26Q40082730-7B3C6F17-2EA5-42D9-95B8-FCE4F44D55D6Q40152615-5037C8FD-F358-4877-8DF4-54EAA1B07868Q40475503-B970BFF2-29ED-4A36-9BAF-333B774E4F71Q43291647-3A4D0EFE-1971-41A8-B967-840E3020ADDAQ47094138-0A48046D-AEF3-4196-9D4F-328220C12558Q47122217-0A39D33B-E837-44C9-A55B-F6B57BF7E452Q47142947-B37966EC-916C-4EA8-BE9F-1D84BFEEC86EQ47407081-95C15533-6C2E-442C-AAC8-D03105742DE0Q47592007-5708F497-95F4-4F12-9D7D-A68FEC67122BQ48289963-18A7B584-0427-4C8C-A6B9-1709EFD2A227Q49732572-4671C450-C2B3-4DB1-AD5F-96707E8BCB43Q56990996-52888031-BB6C-41B1-8B7C-45024B69FB23Q58785196-3CBA1367-29ED-4273-B8D7-980A69DB9CB5
P2860
Association Between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell Carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Association Between PD-L1 and ...... ngeal Squamous Cell Carcinoma.
@en
Association Between PD-L1 and ...... ngeal Squamous Cell Carcinoma.
@nl
type
label
Association Between PD-L1 and ...... ngeal Squamous Cell Carcinoma.
@en
Association Between PD-L1 and ...... ngeal Squamous Cell Carcinoma.
@nl
prefLabel
Association Between PD-L1 and ...... ngeal Squamous Cell Carcinoma.
@en
Association Between PD-L1 and ...... ngeal Squamous Cell Carcinoma.
@nl
P2093
P2860
P356
P1476
Association Between PD-L1 and ...... ngeal Squamous Cell Carcinoma.
@en
P2093
Chung-Hwan Baek
Hae Su Kim
Han Sin Jeong
Ji Yun Lee
Jong-Mu Sun
Keunchil Park
Min-Young Lee
Mineui Hong
Myung-Ju Ahn
Sung Hee Lim
P2860
P304
P356
10.4143/CRT.2015.249
P577
2015-09-15T00:00:00Z